Biomarker Assay Development Using Highly Specific Recombinant Antibodies

This application note demonstrates that high-quality antibodies isolated from the HuCAL PLATINUM^® library can discriminate between agonist and antagonist forms of CXCL10 differing by only two amino acids. Here, Bio-Rad explores how its technology could be used to improve clinical outcomes from hepatitis C virus (HCV) treatment and point to novel targets for therapeutics.